Claim: Retatrutide reduced knee arthritis pain by 75% in clinical trials.
Verdict: Unverified (50% confidence)
Explanation: According to Healio, retatrutide reduced knee arthritis pain by 75% in clinical trials, as participants experienced a significant reduction in pain scores. Rheumatology Advisor also reports that retatrutide led to meaningful pain relief in adults with knee osteoarthritis. Additionally, Lilly's investor release mentions that retatrutide reduced WOMAC pain scores by up to 75.8%. While these sources indicate a notable level of pain reduction, they do not provide peer-reviewed primary research or ma...